Inventor
BEHNKE MARK L
US18 patents
⚠️ This page may combine multiple inventors who share the name “BEHNKE MARK L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INFINITY PHARMACEUTICALS INC
9 patentsUS7812164B2Oct 12, 2010
Cyclopamine analogs
INFINITY PHARMACEUTICALS INC84 citations99
US10406139B2Sep 10, 2019
Cyclopamine analogs
INFINITY PHARMACEUTICALS INC8 citations92
US9492435B2Nov 15, 2016
Cyclopamine analogs
INFINITY PHARMACEUTICALS INC13 citations92
US9951083B2Apr 24, 2018
Cyclopamine analogs
INFINITY PHARMACEUTICALS INC4 citations84
US8349814B2Jan 8, 2013
Inhibitors of fatty acid amide hydrolase
INFINITY PHARMACEUTICALS INC3 citations74
US7947663B2May 24, 2011
Inhibitors of fatty acid amide hydrolase
INFINITY PHARMACEUTICALS INC6 citations74
US11007181B2May 18, 2021
Cyclopamine analogs
INFINITY PHARMACEUTICALS INC1 citations73
US9108989B2Aug 18, 2015
Inhibitors of fatty acid amide hydrolase
INFINITY PHARMACEUTICALS INC1 citations63
US8629125B2Jan 14, 2014
Inhibitors of fatty acid amide hydrolase
INFINITY PHARMACEUTICALS INC3 citations63
BEHNKE MARK L
4 patentsUS9149465B2Oct 6, 2015
Isoxazolines as inhibitors of fatty acid amide hydrolase
BEHNKE MARK L0 citations49
US8765735B2Jul 1, 2014
Isoxazolines as inhibitors of fatty acid amide hydrolase
BEHNKE MARK L1 citations49
US8957049B2Feb 17, 2015
Inhibitors of fatty acid amide hydrolase
BEHNKE MARK L0 citations39
US8927551B2Jan 6, 2015
Isoxazolines as inhibitors of fatty acid amide hydrolase
BEHNKE MARK L0 citations39